| Title |
A Phase I Clinical Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Preliminary Pharmacodynamics of HLX22Monoclonal Antibody Injection in Patients with Advanced Solid Tumours Overexpressing HER2 |
| Description |
To evaluate the safety and maximum to leated dose (MTD) of HLX 22 in patients with advanced or metastatic solid tumours which are non-responsive to standard therapies,screening 20 patients, enrolment 11 Patients. |
| Organism |
Homo sapiens |
| Data Type |
Other Type of Metabolome Data |
| Data Accessibility |
Controlled-access |
| BioProject |
PRJCA014975 |
| Release Date |
2023-02-16 |
| Submitter |
Yanhua Ding (18343115092@163.com) |
| Organization |
The First Hospital of Jilin University |
| Submission Date |
2023-02-15 |